| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |